INTRODUCTION
Liposomes Microscopic phospholipid bubbles with a bilayered membrane structure -have received a lot of attention during the past 30 years as pharmaceutical carriers of great potential. 1 More recently, many new developments have been seen in the area of liposomal drugs -from clinically approved products to new experimental applications, with gene delivery and cancer therapy still being the principal areas of interest. 2 Liposomes are microscopic vesicles composed of a bilayer of phospholipids or any similar amphipathic lipids. They can encapsulate and effectively deliver both hydrophilic and lipophilic substances and may be used as a non-toxic vehicle for insoluble drugs. 3 Liposomes are composed of small vesicles of phospholipids encapsulating an aqueous space ranging from about 0.03 to 10 µm in diameter. 4, 5 The membrane of liposome is made of phospholipids, which have phosphoric acid sides to form the liposome bilayers.Liposomes can be manufacturing in different lipid comopsitions or by different method show variation in par. Size , size distribution, surface electrical potential, no. of lamella, encapsulation efficacy, Surface modification showed great advantage to produce liposomes of different mechanisims, kinetic properties and biodistribution. Products in the market Doxorubicin (Doxil, Myocet) (KS Kaposis sarcoma) Daunorubicin (Dauno Xome) Cytarabin artificial microscopic vesicle consisting of an aqueous core enclosed in one or more phospholipid layers, used to convey vaccines, drugs, enzymes, or other substances to target cells or organs . 6 Liposomes are nano size artificial vesicles of spherical shape. They can be produced from natural phospholipids and cholesterol. Phospholipids combine with water immediately forms a bi-layered sphere .7 On this account Dr. Baumann Cosmetic produces only liposome products without perfume and without chemical preservatives. Exactly the same phospholipids which comprise the liposome membrane form the walls of skin cells. Similarly, the intercellular substance which is found between the skin cells is composed of phospholipids, ceramides, triglyceride, free fatty acids, cholesterol and water. If skin cells are slightly damaged or if the intercellular substance is lost through aggressive cleansing methods, liposomes are able to perfectly replenish the missing lipids. Therefore the combination of phospholipids, ceramides and other skin-endemic lipids .A liposome is a tiny bubble (vesicle), made out of the same material as a cell membrane. Liposomes can be filled with drugs, and used to deliver drugs for cancer and other diseases . 
ATTRACTIVE BIOLOGICAL PROPERTIES OF LIPOSOMES
• Liposomes are biocompatible.
• Liposomes can entrap water-soluble (hydrophilic) pharmaceutical agents in theirinternal water compartment and water-insoluble (hydrophobic) pharmaceuticals intothe membrane.
• Liposome-incorporated pharmaceuticals are protected from the inactivating effect of external conditions, yet do not cause undesirable side reactions.
• Liposomes provide a unique opportunity to deliver pharmaceuticals into cells or even inside individual cellular compartments.
• Size, charge and surface properties of liposomes can be easily changed simply by adding new ingredients to the lipid mixture before liposome preparation LAMELLA A Lamella is a flat plate like structure that appears during the formation of liposomes. The Phospholipid bilayer first exists as a lamella before getting convered into spheres. A Lamella is a flat plate like structure that appears during the formation of liposomes 10 ADVANTAGE  Flexibility in the structure in entrapment of water soluble as well as insoluble drugs.  Biodegradability  Efficient control of release.  Resemblance to natural membrane structures.  Increased targeting prospects. Biocompatible, completely biodegradable, non-toxic, flexible ,nonimmunogenic.  Liposomes supply both a lipophilic environment and aqueous "milieu interne" in one system. Can protect encapsulated drug.  Reduce exposure of sensitive tissues to toxic drugs. .  Easy to construction.  Increased efficacy and therapeutic index.  Provides both targetting active and passive.  Does not accumulate in heart and so there is no cardiotoxicity.  Prevent oxidation of the drug.
DISADVANTAGE
 Production cost is high.  Leakage and fusion of encapsulated drug / molecules.  Sometimes phospholipid undergoes oxidation and hydrolysis like reaction.  Short half-life.  Low solubility.  Fewer stables. The development of liposomes at industrial level is difficult due to its physiological and physicochemical instability.  They are prone to degradation by oxidation and hydrolysis.  Production cost is high.  Leakage and fusion of encapsulated drug / molecules.
 Low solubility  Fewer stables.
COMPOSITION OF LIPOSOMES

A. Phospholipids
Naturally occurring phospholipids used in liposome
• Synthetic phospholipids used in the liposomes are:
• Dioleoyl phosphatidylcholine
• Disteroyl phosphatidylcholine
• Dioleoyl phosphatidylethanolamine 11
B. Cholesterol
Cholesterol can be incorporated into phospholipids membrane in very high concentration up to 1:1 or 2:1 molar ratios of cholesterol to phospatidylcholine. Being an amphipathic molecule, cholesterol inserts into the membrane with its hydroxyl group of cholesterol oriented towards the aqueous surface and aliphatic chain aligned parallel to the acyl chains in the center of the bilayers and also it increase the separation between choline head groups and eliminates the normal electrostatic and hydrogen bonding interaction. The phospholipids are arranged in such a way that the hydrophilic head is exposed outside and the lipophillic tails are aliened inside. This makes the liposomes water soluble molecules .
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Fig. -5: Structure of liposome overall composition 7  As liposomes are made up of phospholipids, they are amhpipathic in nature and have ability to binds both aqueous and polar moiety.They have polar head and non polar tail.
 The polar end is mainly phosphoric acid and it will bound to water soluble molecule.
 In aqueous medium the molecules in self-assembled structure are oriented in such way that the polar portion of the molecule remain in contact with in polar environment and at same time shields the non polar part. Liposomes are formed when the thin films are hydrated and stacks of liquid crystalline bilayers become fluid and swells. 
PHYSICAL DISPERSION OR MECHANICAL DISPERSION METHOD
Aqueous volume enclosesd usiong this method usually 5-10%,which is very small proportion of total volune used for swelling .Therefore large quantity of water -soluble compound are wasted during sweeling .On the other hand lipid soluble compound cab be encapsulated to 100% efficacy ,provided they aee not present in quantities that are greater than the structural component of the memberane.
Lipid Film Hydration by hand shaking and non hand shaking:-In this methods, the lipids are casted as stacks of film from their organic solution using "Flash rotatory evaporator" or "hand shaking",The film formation will be takes place and the film will be dried in presence of reduced Nitrogen.After the film stacks are dispersed in aqueous phase .Upon hydration the liquid will swell and peel off from wall of round bottom flask and vesiculate forming multi lamellarvesicles(MLVs).Liposomes stored under the nitrogen umbrella store . 
Step1
Lipid mixture of different phospholipid and charge components in chloroform :methanol solvent mixture (2:1v/v) is prepared first and then introduced into a round bottom flask with a ground glass neck,This flask is then attached to a rotary evaporator and rotated at 60 rpm.The orgnic solvent are evaproted at about 30 degree Celsius or above the transition temperature of the lipids usedThe evaprotor is isolated from the vaccume source by closing the tep.The nitrogen is introduced into the evaporator and the pressure at the cylinder head is gradually raised till there is no difference between inside and out side the flask.The flask is then removed from the evaproter and fixed on to the manifold of lyophilizer to remove residual solvents
Step2-hydration of lipid layer
After releasing the vacume and removal from the lyophilizer ,the flask is flushed with nitrogen,5 ml of saline phosphate buffer (containing solute to be entrapped )is added.The flask is attached to the evaporator again (flushed with N 2 )and rotated at room temperature and pressure at the same speed or below 60 rpm.The lask is left rotating for 30 minutes or unti all lipid has been removed from the wall of the flask and has given homogenous milky -whjite suspension free of visible particles.The suspension is allowed to stand for a further 2 hours at room temperature or at a temperature above the transition temparature of the lipid in order to complete the sweeling process to give MLVs .14
Fig 9: Method of preparation of liposomes by hydration of lipid SHAKING VESICLES
Method described by reeves and dowben in 1996 by which large unicellular vesicles (LUVv) can be formed with higher entrapment volume.The procedure differs from hand shaken method in that it uses a stream of nitrogen to provide agitation rather than the rotationary movements.Solution of lipid in chloroform :methanol mixture is spred over the flat bottom conical flask.The solution is evaproted at room temparature by flow of nitrogen through the flask without disturbing the solutionAfter drying water saturated nitrogen is passed through the flask untill the opacity of the dried film disappears (15-20 mins).After hydration ,lipid is swelled by addition of bulk fluid .the flask is inclined to one side ,10-20ml of 0.2 sucrose in distilled water (degassed)is introduced down the slide of the flask ,and the flask is slowly returned to upright orientation.The fluid is allowed to run gently over the lipid layer on the bottom of the flaskThe flask is fluhed with nitrogen ,sealed and allowed to stand for 2hours at 37 degrees celsius .take care not to disturb the flask in any way.Aftre swelling ,the vesicles are harvested by swirling the contents ,to yield a milky -suspention .
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BUCHI ROTATORY EVAPORATOR NON SHAKING METHOD & PRO -LIPOSOMES:
Pro liposomes method devised to increase the surface of dry lipid while keeping the low aqueous volume In this method , the lipid are dried down to finely divided particulate support ,such as powered sodium chloride,or sorbitol or other polysacchride-to give proliposomes.The lipid are swelled upon adding water to dried lipid coated powered (pro-liposomes),where the support rapidly dissolves to give a suspention of MLVs in aqueous solution.The size of the carrier influence the size and hetrogeneity of the liposomes.This method overcomes the problem encountered when storing liposomes themselves in either liquid ,dry or frozen form ,and ois ideally suited for prparation where the material to be entrapped incoropted into lipid membrane,In case where 100% entrapment of aqueous component is not essential ,this method is also of valve.For preparing proliposomes a special equipment i.e.buchi rotary evaproter " R"with water cooled condensor coil and a stainless steel covered thrmocouple connected to a digital thermometer is required.The end of glass solvent inlet tube is modified to a fine point ,so that the solvent is introdused into the flask as a fine spray .
Fig 10: Method of preparation of liposomes by buchi rotatory evaporator SONICTION:
This is the method in which Multi lamellar vesicles are transformed to the small uni lamellar vesicles. The ultra sonic irradiation is provided to the MLVs to get the SUVs. There are two methods are used. a) Probe sonication method., b) Bath sonication method.The probe is employed for dispersion, which requires high energy in small volume (e.g. high conc. of lipids or a viscous aqueous phase) while is more suitable for large volumes of diluted liquid Probe tip sonicator provides high energy input to the liquid dispersion but suffer from overheating of liposomal dispersion causing lipid degradation. sonication tip also release titanium into the liposome dispersion which will be removed from the it by centrifugation prior to use. Due to above reason most widely the bath sonicators are used Sonication of MLVs is accomplished by placing dispersion into the the bath sonicator or placing tip fo probe sonicator into the test tube of dispersion.(5-10 min.)After sonication applied the resultant dispersion is centrifuged and according to diagram the SUVs will stay on the top and the small MLVs and aggregated lipids will get settled down. The top layer constitutes pure dispersion of SUVs with varying diameter as size is influenced by composition and concentration, temperature, sonication, volume and sonication tuning. This method is having the mechanism of high pressure.This method will give the either uni-or oligolamellar liposomes of intermediate size (30-80nm) , these liposomes are more stable compared to the sonicated liposomes.This method is having some drawbacks are that initial high cost for the press and the pressure cell liposomes prepared by this method having less structural defects unlike sonicated liposome .
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MICRO EMULSIFICATION LIPOSOMES:-
"Micro fluidizer" is used to prepare small MLVs from concentrated Lipid dispersion.Micro fluidizer pumps the fluid at very at very high pressure (10,000 psi), through a 5 micrometer orifice.Then, it is forced along defined micro channels which direct two streams of fluid to collide together at the right angles at a very high velocity, there by affecting an efficient transfer of energy.The lipids can be introduced into the fluidizer, either as large MLVs or as the slurry of un hydrated lipid in organic medium. The fluid collected can be recycled through the the pump and interaction chamber until vesicles of spherical dimensions are obtained. diameter After a single pass, the size of vesicles is reduced to a size 0.1 and 0.2um .
MEMBRANE EXTRUSION TECHNIQUE
The technique can be used to process LUVs as well as MLVs.The size of liposomes is reduced by gently passing them through membrane filter of defined pore size achieved at much lower pressure(<100psi). In this process, the vesicles contents are exchanged with the dispersion medium during breaking and resealing of phospholipids bilayers as they pass through the polycarbonate membrane. The liposomes produced by this technique have been termed LUVETs. This techniques is most widely used method for SUV and LUV production for in vitro and in vivo studies .
Fig 12: Method of preparation of liposomes by sonicaton DRIED RECONSTITUTED VESICLES (DRVS):-
This method starts with freeze drying of a dispersion of empty SUVs. After freeze drying the freeze dried membrane is obtained.Then these freeze dried SUVs are rehydrated with the use aqueous fluid containing the material to be entrapped. This leads to formation of the solutes in uni-or oligo-lamellar vesicles .
FREEZE THAW SONICATION:
This method is based upon freezing of a unilamellar dispersion(SUV). Then thawing by standing at room temperature for 15min.Finally subjecting to a brief Sonication cycle which considerably reduces the permeability of the liposomes membrane. In order to prepare GIANT VESICLES of diameter between 10 and 50um, the freeze thaw technique has been modified to incorporate a dialysis step against hypo-osmolar buffer in the place of sonication. The method is simple, rapid and mild for entrapped solutes, and results in a high proportion of large unilamellar vesicles formation which are useful for study of membrane transport phenomenon.This method is based upon freezing of a unilamellar dispersion(SUV). Then thawing by standing at room temperature for 15min. Finally subjecting to a brief Sonication cycle which considerably reduces the permeability of the liposomes membrane. In order to prepare GIANT VESICLES of diameter between 10 and 50um, the freeze thaw technique has been modified to incorporate a dialysis step against hypo-osmolar buffer in the place of sonication. The method is simple, rapid and mild for entrapped solutes, and results in a high proportion of large unilamellar vesicles formation which are useful for study of membrane transport phenomenon. this method prepaer ULVs from MLVs without sonication or high pressure application ,they are reassembled by simply charging the ph .it is an electrostatic phenomenon ,the transfering chage in PH bring about an increase in the surface charge density of lipid bilayer ,provided this exceeeds a certain threshold valve of around 1-2uc/cm 2 ,spontanous vesiculation will occur .the period of exposure of the phospholipid to high ph is less than 2min s and not long enough to cause detectable degratation of phospholipd.In this method ,dry film of lipid is obtained is the round bottom flask usin the rotatory evaporator and last traces of the solvent are removed using freeze dryer.Then,the film is hydrated with minimum quantity of water by hand shaking at room temperature .At this stage material to be entrapped inside the vesicles may be added in the water before adddition to the lipid.The dispersion is completed by subjecting the suspention to six freeze thawing cycle between 15 degree cesilsius and 5 degrees celsius.the PH of the despersion will be 2.5-3Sodium hydroxide solution (1m)is added rapidly with mmixing into the suspension then then the PH is redused by addition of 0.1m hcl until a valve of PH 7.5 is achieved. 
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CALCIUM INDUSED FUSION
It uses concept of aggregation and fusion of acid phospholipid vesicles in the presence of calcium .In this method ,lipid is dried down and suspended in sonication buffer (Nacl 0.385g,histidin 31.0 mg ,this -base 24.2 mg ,water 100ml ,PH 7.4)The large liposomes and lipid particles are removed by centrifugation at 100,000g.Equimolar proportion of calcium solution precipite is formed It is incubeted for 60 mins at 37 degree celsius and the precipitate is separated by spinning the container at 3000g for 2o min at room temperature .the supleemantant is dscarded.The pellet is resuspended is buffered saline containing the material to be entraped and incubated at 37 degrees celsius for 10 min The EDTA (170mm) is added in buffer with mixing The cloudy precipite will clear rapidly ,then incubate for 15 min at 37 degree celsius and further 15 min mix at room temparature.Finally,the ca/EDTA complex is removed by dialysing again a litre of buffer.
REVERSE PHASE EVAPORATION VESICLES:
Sonicated methods (stable plurilamellar vesicles -SPVs) in this method ,w/o dispersion is prepared as described earlier with excess lipid ,but drying process is accompanined by continued bath sonication with a stream of nitrogen.The redistribution and equilibration of aqueous solvent and solute occur this time in between the various bilayer in each plurilamellar vesicles The internal structure of SPVs is different from that of MLV-REV,in that they lack a large aqueous medium being located in compartment in between adjucent lamellae.the percent entrapment is normally 30 % .
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DETERGENT REMOVAL METHODS
Detergent/Phospholipids mixtures can form large unilamellar vesicles upon removal of non ionic detergent using appropriate adsorbents for the detergent. in this method ,the phospholipid are brought into intimate contact with the aqueous phase via the intermediary of detergent ,which associated with phospholipid molucule from water,In structural formed as a result of this associated are known as micelles ,and can be composed of several hundred component molecules.Their shape and size depend on chemical nature of the detergent ,the concentration and other lipid involved.The concentrated of detergent in water at which micelles from is known as critical micelle concentration(CMC) .
18,19
REMOTE OR ACTIVE LOADIND
The membrane from lipid bilayer is in general impermeable to ions and larger hydrophilic molecules Ion transport can be regulated by the ionophores while permeation of neutral and weakly hydrophobic moleculescan be controlled by c oncentration gradients.Some weak acids or bases howeve r, can be transported through the membrane due to various trans membrane gradients, such as electrical, ionic (pH) or specific salt(ch emical potential) gradiens Several 
SIZE AND ITS DISTRIBUTION
Most precise method to determine size of the liposome is by electron microscopy, since it allows to view each individual liposome and to obtain exact information about the profile of liposome population over the whole range of sizes. Unfortunately it is very time consuming and requires equipments thatmay not always be immediately available to hand .In contrast, laser light scattering (quasi-elastic laser light scattering) method is very simple and rapid to perform but having disadvantage of measuring an average property of the bulk of the liposomes.
21,22
MICROSCOPIC METHODS
Light microscopy has been utilized to examine the gross size/distribution o f large vesicles produced from single chain amphiphilesIf the bilayers are having fluorescent hydrophilic probes, the liposomes can be examined under a fluorescent microscope. 
GEL PERMEATION
Exclusion chromatography on large pure gels was introduced to separate SUVs from radial MLVs.However, large vesicles of 1-3 um diameter usuall y failto enter the gel and are retained on the top of the column.A thin layer chromatography system using agaro se beads has been introduced as a convenient, fast technique for obtaining a rough estimation of the size distribution of a liposomes preparation. However, it was not reported if this procedure was sensitive to a physical blockage of the pores of the agarose gel as is the more conventional column chromatography.
B) SURFACE CHARGE
A method using free flow electrophoresis is used to dete rmine the surface charge of MLVs, A technique has been developed that separates extruded ves icles on the basis of their surface charge by electrophoresis on a cellulose acetate plate in a sodium borate buffer pH 8.8. The lipid samples (5 nmoles) are applied to the plate and electrophoresisis carried out at 4 degrees Celsiuson a flat bed apparatus for 30 mins at 18 V/cm.The plate is dried and the phospholipids are visuali zed by the molybdenum blue reagent. Liposomes upto 0.2 um in diameter can migrate on this support and with this technique as little as 2 mole % of charged lipids can be detected in a liposome bilayer. This sensitive assay should prove valuable for examining the charge heterogeneity in liposome preparation for following fusion between two populations of vesicles with different charge and for determining.
C) PERCENT CAPTURE (ENTRAPMENT)
It is essential to measure the quantity of material entrapp ed in side liposomes before the study of behavior of this entrapped material in physical and biological systems, since the effects observed experimentally will usually be dose related. After removal of un incorporated material by the separation techniques, one may assume that the quantity of material remaining is 100% entrapped, but the preparation may change upon storage. For long term stability test and for developing new liposome formulation or method of preparation, a technique is needed for separating free from entrapped material. 22, 23, 24 MINI COLUMN CENTRIFUGATION METHOD In this method, the hydrated gel (sephadexG-50) is filled in a barrel of 1mL syringe without plunger which is plugged with a whatman GF/B filter pad. This barrel is rested in a centrifuge tube. This tube is spun at 2000 rpm for 3 mins to remove excess saline solution fromthe gel. After centrifugation the gel column should be dried and have come away from the side of the barrel Then, eluted saline is removed from the collection tube.Liposome suspension (0.2mL undiluted) is applied drop wise to the top of the gel bed, and the column is spun at 2000 rpm for 3 min. to expel the void volume containing the liposomes into the centrifuge tube.The elute is then removed and set a side for assay. 23, 24, 25 
D)ENTRAPPED VOLUME
The entrapped volume of a population of liposomes (inu L/mg phospholipid) can often be reduced from measurements of the total quantity of solute entrapped in side liposomes assuring that the concentration of solute in the aqueous medium inside liposomes is the same as that in the solution used to start with, and assuming that no solute has leaked out of the liposomes after separation from unentrapped material.However, in many cases such assumption is invalid. For e.g.,in two phase methods of preparation, water can be lost from the internal compartment during the drying down step to remove organic solvent. 25, 26, 27 
E) LAMELLARITY
The average number of bilayers present in a liposome can be found by freeze electron microscopy and by 31P-NMR.In the latter technique, the signals are recorded before and after the addition of broadening agent such as manganese ions which inteact with the outer leaflet of the outer most bilayers. Thus, a 50% reduction in NMR signal means that the liposome preparation is unilamellar and a 25% reduction in the intensity of the original NMR signal means that there are 2 bilayers in the liposom Nowadays, freeze fracturing electron microscopy hasbecome a very popular methd to study str uctural details of aqueous lipid dispersions. Phase Behavior of Liposomes An important feature of lipid membrane is the existence of a temperature dependant, reversible phase transition, where the hydrocarbon chains of the phospholipid undergo a transformation from an ordered (gel) state to a more disordered fluid (liquid crystalline) state.These change have been documented by freeze fracture electronmicroscopy, but most easily de monstrated by differential scanning calorimetery.
The physical state of the bilayers pro foundly affects the permeability, leakage rates and overall stability of the liposomes. The phase transition temperature (Tc) is a function of phospholipid content of the bilayers.The Tc can give good clues regarding liposomal stability, permeability and whether drug is entrapped in the bilayer s or the aqueous compartment.
DRUG RELEASE
The mechanism of drug release from the liposomes can b eassessed by the use of a well calibrated in vitro diffusio n cell.The liposome based formulations can be assisted by employing in vitro assays to predict pharmacokinetics and bioavailability of the drug before employing costly and time-consuming in vivo studies. The dilution-induced drug release in buffer and plasma was employed as predictor for pharmacokinetic performance of liposomal formulations and another assay which determined intracellular drug release induced by liposomes degradation in the presence of mouse-liver lysosome lysate was used to assess the bioavailability of the drug. 28, 29, 30 
CHEMICAL CHARACTERIZATION
A) QUANTITATIVE DETERMINATION OF PHOSPHOLIPIDS
It is difficult to measure directly the phospholipid concentration, since dried lipids can often contain considerable quantities of residual solvent. Consequently the method most widely used for determination of phospholipidis an indirect one in which the phosphate content of the sample is first measured , The phospholipids are measured either using Bartlett assay or Stewart Assay . 29, 30, 31 Bartlett Assay In the Bartlett assay the phospholipid phosphorous in the sample is first hydrolyzed to inorganic phosphate. This is converted to phospho-molybdic acid by the addition ammonium molybdate and phospho-molybdic acid is quantitatively to a blue colored compound by amino-naphthyl-sulfonic acid. The intensity of the blue color is measured spectrophotometrically and is compared with the curve of standards to give phosphorous and hence phosphorlipid content Bartlett assay is very sensitive but is not reasonably reproducible.
The problem is that the test is easily upset by trace contamination with inorganic phosphate. Therefore, precaution is to be taken using a set of borosilicate glass tubes which are washed well and not usedfor any other purpose.Use of double-distille d water for making up solutions.The sensitivity of the Ba rtlett assay to inorganic phosphate creates problem with measurement of phospholipid liposomes suspended in physiological buffers, which usually contain phosphate ions. This can beovercome by employ ing a more specific method which Is unaffected by inorganic phosphate. 32, 33 
STEWART ASSAY
In Stewart assay, the phospholipid forms a complex with ammonium ferrothiocyanate in organic solution.The advantage of this method is that the presen ce ofinorganic phosphate does not interfere with the assa y.This method is not applicable to samples where mixture of unknown phospholipids may be present.In this method, the standar d curve is first prepared byadding ammonium ferrothiocy anate(0.1M) solution with different known concentrations of phospholipids in chloro form. Similarly, the samples are treated and optical density of these solutions is measured at 485nm the absorbance of samples compared with the standard curve of phospholipids to get the concentration.
B) PHOSPHOLIPIDS OXIDATION
Oxidation of the fatty acids of phospholipids in the abse nceof specific oxidants occurs via a free radical chain mechanism.
The initiation step is abstraction of a hydrogen atom from the lipid chain that can occur most commonly as a result ofe xposure to electro-magnetic radiation or trace amount of contamination with the transition metal ions. Polychain-saturated lipids are particularly prone toxidative degradation.A nu mber of techniques are available for determining the oxidation of phospholipids at different stages i.e., UVabsorbance method, TBA method (for endoperoxides), iodometric method (for hydroperoxides) and GLC method. 33, 34, 35 
C) CHOLESTEROL ANALYSIS
Cholesterol is qualitatively analyzed using capillary column of flexible fused silica where as it is quantitatively estimated (in therange of 0-8ug) by measur ing the absorbance of purple complex produced with iron upon reaction with a combined reagent containing ferric per chlorate , ethyl acetate and sulfuric acid at 610nm.
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APPLICATION
Application Utilized
Liposomes in bioengineering
Modern genetic engineering and gene recombinant technology is based on the deliveryof genetic material, i.e. fragments of DNA, into various cells and microorganismsin order to alter their genetic code and force them to produce particular proteins or Polypeptides Medical applications of stealth liposomes Sterically stabilised vesicles can act either as long circulating microreservoirs or tumour (or site of inflammation and infection) targetting vehicles. The former application srequires larger liposomes (_ 0.2 _m) while the latter one is due to the ability of small vesicles to leave the blood circulation 38 
Liposomes in anticancer therap
These cells are in tumours, but also in gastrointestinal mucosa, hair, and blood cells and therefore this class of drugs are very toxic. The most used andstudied is Adriamycin (commercial name for Doxorubicin HCl).
Macrophage activation and vaccination
The automatic targetting of liposomes to macrophages can be exploited in several other ways, including the macrophage activation and in vaccination Liposomes in parasitic diseases and infections Since conventional liposomes are digested by phagocytic cells in the body after intravenous administration, they are ideal vehicles for the targetting of drug molecules into these macrophages Applications of liposomes in basic sciences Lipid membranes are two dimensional surfaces floating in three dimensional space.In the simplest models, they can be characterised only by their flexibility which is related to their bending elasticity. 39, 40 Application of liposomes in agrofood industry
The ability of liposomes to solubilize compounds with demanding solubility properties, sequester compounds from potentially harmful milieu, and release incorporated molecules in a sustained and predictable fashion can be used also in the food processing industry For instance, lecithin and some other polar lipids are routinely extracted from nutrients, such as egg yolks or soya beans .40,41 
WORLD MARKET OF LIPOSOMES:
The liposomes are among the drug carrier being extensively used today. This category of drug delivery system has occupied a major area in the world market. There is no place in the world left where liposomes have not been marketed. Among the major areas Western Europe with 13% of the total market dominates followed by North America and South Asia with contribution of 12% and 11% respectively. The area like Oceania is also influenced by the liposomal preparations and contributed approximately 8% to the world market. 51, 52, 53 
CONCLUSION:
This review presented the hardest aspect of choice for any material. Since they have been discovered in the 60"s by Bingham, liposomes have drawn attention of researchers. Nowadays, they always remain a topical issue; new preparation methods have been developed as well as new characterization techniques. In the pharmaceutical field, liposome"s have long been of great interest by offering a promising way for both systemic and locally acting drugs used for therapeutic applications in humans and animals. As a result of the great potential of liposomes in the area of drug delivery, several companies have been actively engaged in expansion and evaluation of liposome products. Most of them concern anticancer and antifungal drugs that, administered in their free form, are toxic or exhibit serious side-effects and their encapsulation into liposomal vesicles significantly diminishes these unwanted properties. With these requirements met, we are surely likely to see more liposomal pharmaceuticals on the market in the foreseeable future.
